Precision Oncology and the Evolution of Tyrosine Kinase Inhibitors How is molecular profiling redefining the treatment algorithm for GIST?
The management of Gastrointestinal Stromal Tumors (GIST) has shifted from a one-size-fits-all surgical approach to a highly segmented medical strategy. Understanding the specific mutations in the KIT or PDGFRA genes is now the clinical standard before initiating therapy. This allows clinicians to predict response rates and...